U.S. Preventive Services Task Force wants to close evidence gaps
This article was originally published in The Gray Sheet
Executive Summary
Agency for Healthcare Research and Quality seeks comments through May 14 on draft methodology for establishing research priorities in the area of clinical preventive services. The effort will support research on topics that have critical evidence gaps and for which the USPSTF has issued a statement of insufficient evidence, AHRQ says. The draft methodology considers prioritizing the so-called "I" statements by research importance and the process for considering research feasibility
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.